Northland Capital Markets Starts Sensus Healthcare (SRTS) at Outperform (Earlier)

August 8, 2016 10:47 AM EDT
Get Alerts SRTS Hot Sheet
Price: $4.99 +3.96%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade SRTS Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Northland Capital Markets initiates coverage on Sensus Healthcare (NASDAQ: SRTS) with a Outperform rating and a price target of $8.00.

Analyst Suraj Kalia commented, "We are initiating coverage of Sensus Healthcare with an Outperform rating / $8 PT, which represents 6x forward P/S. Sensus superficial x-ray therapy (SRT) presents a unique tool in the armamentarium of treating non-melanoma skin cancer, keloids, psoriasis and intra-operative radiation. Our constructive stance is a reflection of SRT's ability to improve ROI for clinicians while providing similar / better clinical outcomes for patients, without the side effects associated with traditional therapy."

For an analyst ratings summary and ratings history on Sensus Healthcare click here. For more ratings news on Sensus Healthcare click here.

Shares of Sensus Healthcare closed at $6.35 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Add Your Comment